Peptide Reconstitution Guide: Bacteriostatic Water and Acetic Acid Water

Proper reconstitution and storage of lyophilised research peptides is essential for maintaining compound integrity and ensuring reproducible research results. This guide covers the standard reconstitution vehicles supplied by Signal Laboratories — bacteriostatic water and acetic acid water — and provides detailed protocols for peptide preparation, storage, and quality control in research laboratory settings.

Why Lyophilisation?

All Signal Laboratories research peptides are supplied as lyophilised (freeze-dried) powder to maximise stability and shelf life. Lyophilisation removes water from the peptide solution by freezing then sublimating the ice under vacuum, leaving a dry powder that is substantially more stable than the equivalent solution at any temperature. Lyophilised peptides are stable at -20°C for 2 or more years with minimal degradation — reconstituted peptide solutions have substantially shorter stability (days to weeks at 4°C, months at -20°C).

Lyophilised powder should appear as a white, off-white, or cream coloured fluffy powder that dissolves readily in an appropriate reconstitution vehicle. Exceptions: GHK-Cu and AHK-Cu appear blue-green due to copper coordination; some highly hydrophobic peptides may appear as a thin film rather than fluffy powder.

Reconstitution Vehicles

Bacteriostatic Water

Bacteriostatic water is sterile water for injection containing 0.9% benzyl alcohol as antimicrobial preservative. It is the standard reconstitution vehicle for the majority of research peptides and is appropriate for all Signal Laboratories products unless the product description specifically indicates acetic acid water is required.

When to use bacteriostatic water:

• BPC-157, TB-500, GHK-Cu, Ipamorelin, CJC-1295, GHRP-2, GHRP-6, Sermorelin, Hexarelin, Thymosin Alpha-1, NAD+, SS-31, MOTS-c, KPV, Kisspeptin-10, LL-37, and the vast majority of the Signal Labs catalogue
• Any peptide that produces a clear, colourless (or appropriately coloured) solution when dissolved in bacteriostatic water
• When working concentrations will be used within 2-4 weeks (store reconstituted solution at 4°C)

Reconstitution protocol:

1. Allow sealed peptide vial and bacteriostatic water vial to equilibrate to room temperature (10-15 minutes)
2. Wipe both rubber stoppers with 70% isopropanol, allow to dry
3. Using a sterile syringe, withdraw the desired volume of bacteriostatic water
4. Insert needle through rubber stopper of peptide vial
5. Inject bacteriostatic water slowly down the inside wall of the vial — do not inject directly onto lyophilised powder
6. Gently swirl the vial in a circular motion until fully dissolved — do not vortex
7. The solution should be clear and free of particulate matter before use

Recommended stock concentration: 1mg/mL (e.g., add 1mL bacteriostatic water to a 1mg peptide vial) provides a convenient stock for serial dilution to nanomolar working concentrations.

Acetic Acid Water (0.6%)

Acetic acid water is sterile 0.6% v/v glacial acetic acid in sterile water (approximately pH 3.5), used for peptides with limited solubility at neutral pH. The acidic environment protonates basic residues (Lys, Arg, His), maintaining peptide in its cationic form that is soluble through electrostatic repulsion between molecules.

When to use acetic acid water:

• IGF-1 LR3 — must be dissolved in acidic solution (0.1% acetic acid or similar) before dilution in neutral media. Direct reconstitution in bacteriostatic water causes precipitation
• Any peptide producing cloudiness, precipitation, or particulate matter in bacteriostatic water — switch to acetic acid water
• Growth hormone fragments and highly cationic peptides with multiple Lys/Arg residues

Reconstitution protocol:

1. Dissolve lyophilised powder in minimum volume of 0.6% acetic acid water (typically 0.5-1mL) to produce a concentrated acidic stock
2. Confirm dissolution — solution should be clear
3. Immediately before use, dilute acidic stock into the appropriate neutral buffer or cell culture medium. The buffering capacity of PBS (10mM phosphate) or HEPES buffer will neutralise the small acetic acid volume
4. Final working solution pH should be within 6.5-7.5 for cell-based assays — verify with pH strip or pH meter if using high volumes of acidic stock

Storage Protocols

Lyophilised peptides:

• Store sealed, unopened vials at -20°C (standard peptides) or -80°C (peptides containing Met, Cys, or Trp, and complex compounds like GLP-1 analogues)
• Protect light-sensitive peptides (those containing Trp, Tyr, or Met) from UV by wrapping in foil or using amber containers
• Allow sealed vials to equilibrate to room temperature before opening to prevent moisture condensation on the cold powder

Reconstituted solutions:

• Short-term (days to 2-4 weeks): store at 4°C
• Long-term (weeks to months): aliquot into single-use volumes in 0.5mL or 1.5mL microcentrifuge tubes and store at -20°C. Label with: peptide name, concentration, reconstitution date, reconstitution vehicle
• Avoid repeated freeze-thaw cycles — each cycle can cause peptide aggregation and potency loss. Aliquot single-use volumes before freezing

Quality Control

Visual inspection before use: Every reconstituted peptide solution should be inspected visually before use. Expected appearance: clear, colourless (most peptides), pale yellow (NAD+), blue-green (GHK-Cu, AHK-Cu). Discard any solution showing: visible turbidity or cloudiness, visible particulate matter, unexpected colour change, or any sign of contamination.

Sterility maintenance: Always use sterile syringes and needles. Wipe rubber stoppers with 70% isopropanol before every puncture. Never touch needle tips to non-sterile surfaces. Store bacteriostatic water vials at 4°C after first puncture and use within 28 days.

Concentration verification (for critical research): For experiments where precise peptide concentration is essential, verify concentration of reconstituted stock by UV absorbance at 280nm (for Trp/Tyr-containing peptides using calculated extinction coefficient) or by BCA/Bradford assay (less specific, suitable for quality control).

Common Reconstitution Problems and Solutions

Peptide does not dissolve: Try warming to 37°C briefly with gentle swirling. If cloudiness persists in bacteriostatic water, switch to 0.6% acetic acid water. If cloudiness persists in both vehicles, try DMSO at 10-50% for initial dissolution, then dilute into aqueous media.

Solution is cloudy after previously being clear: May indicate peptide aggregation from freeze-thaw, pH change, or bacterial contamination. Do not use — discard and reconstitute fresh from lyophilised stock.

Very small peptide mass (less than 1mg): Electrostatic charge can cause powder to adhere to vial walls. After adding reconstitution vehicle, let the vial stand for 5 minutes, then gently swirl — the liquid contact will dissolve powder adhering to glass walls.

Key Published Research

• Bhatt DK, et al. "Lyophilization of protein pharmaceuticals." BioPharm International, 2014.
• Carpenter JF, et al. "Mechanisms of protein stabilization in the solid state." Journal of Pharmaceutical Sciences, 1997.
• Chang BS, Hershenson S. "Practical approaches to protein formulation development." Pharmaceutical Biotechnology, 2002.

All Signal Laboratories products are for laboratory and analytical research purposes only. Not for human or veterinary administration.

Advanced Peptide Handling for Specific Research Applications

Certain Signal Laboratories research compounds require additional handling considerations beyond standard bacteriostatic water reconstitution. Understanding these compound-specific requirements ensures research-grade peptide solutions throughout the experiment.

GHK-Cu and AHK-Cu (copper peptides): Reconstitute in bacteriostatic water at 1mg/mL — the solution will be blue-green, confirming intact copper coordination. Never use reducing agents (DTT, TCEP, BME, glutathione) in any buffer or medium used with copper peptides — reducing agents disrupt the Cu(II) coordination, releasing free copper ions and destroying the peptide's biological activity. The blue-green colour should persist throughout the experiment; loss of colour indicates copper dissociation.

LL-37 (amphipathic peptide): LL-37 self-aggregates at concentrations above approximately 5µM at neutral pH. Prepare concentrated stocks in sterile water (not PBS — salt promotes aggregation), aliquot immediately into single-use volumes. Dilute to working concentrations immediately before addition to cells. Aggregated LL-37 shows reduced biological activity and increased non-specific membrane disruption — use DLS (dynamic light scattering) to confirm monomeric state at your working concentration.

SS-31 (Elamipretide): Highly water-soluble cationic peptide — dissolves readily in sterile water at 10mg/mL. Store reconstituted solutions at 4°C, stable for 2 weeks. The cationic character (4 positive charges at pH 7.4) means SS-31 adsorbs to anionic surfaces — use low-binding tubes and pipette tips for SS-31 solutions at sub-nanomolar concentrations.

Matrixyl (palmitoyl pentapeptide): Prepare 10mM stocks in DMSO or ethanol. The C16 palmitoyl chain makes Matrixyl insoluble in aqueous media at concentrations above approximately 100µM — always prepare concentrated organic stocks and dilute into aqueous media maintaining less than 1% organic solvent. Prepare working solutions immediately before use.

pH Verification for Cell Culture Research

Most cell culture media contain sufficient buffering capacity (bicarbonate or HEPES) to neutralise the small volumes of acidic reconstitution vehicles used. However, for research requiring precise pH control — such as chondrocyte culture (pH optimum 7.0-7.2 for cartilage ECM synthesis), primary neuron culture (highly sensitive to pH shifts), or GPCR functional assays (where pH affects receptor conformation) — verify the final pH of reconstituted peptide in your specific medium using a calibrated micro pH electrode or narrow-range pH strips before adding to cells.

The calculation: a 1mg/mL Matrixyl stock in DMSO diluted 1:1000 into DMEM (with 3.7g/L NaHCO3 bicarbonate buffer, approximately 25mM) adds a negligible organic volume with essentially no effect on pH. But a 1mg/mL IGF-1 LR3 stock in 0.6% acetic acid (pH 3.5) diluted 1:100 into unbuffered saline would add 0.06% acetic acid — sufficient to measurably reduce pH. The same volume added to 25mM HEPES or bicarbonate-buffered DMEM would be neutralised effectively. Always calculate the acid molar contribution before use and verify if in doubt.

Lyophilised Peptide Receipt and Quality Verification

Upon receipt of Signal Laboratories research compounds, perform a visual quality check before storage. The lyophilised powder should appear: fluffy or cotton-like texture (indicates good lyophilisation); white or off-white colour (most peptides); blue-green (GHK-Cu, AHK-Cu — confirms copper coordination); or a thin glassy film (small quantities of highly soluble peptides, normal appearance). Red flags requiring contact with Signal Labs support: brown or discoloured powder (indicates degradation or contamination); liquid or semi-liquid contents (failed lyophilisation or temperature excursion during transit); vial with broken seal or stopper displacement (sterility compromise).

Store received vials immediately at the specified temperature (-20°C standard, -80°C for Met/Cys-containing peptides) without opening. Labelling: add receipt date and lot number to the vial label immediately on receipt. For research reproducibility, always record the lot number used in experimental notebooks alongside the product name and concentration.

Key Published References

• Carpenter JF, Chang BS. "Lyophilization of protein pharmaceuticals." Biotechnology and Biopharmaceutical Manufacturing, 1996. PMID: 8925523
• Wang W. "Lyophilization and development of solid protein pharmaceuticals." International Journal of Pharmaceutics, 2000. PMID: 10794987
• Bhatt DK, et al. "Stability of peptide drugs: practical considerations for storage and reconstitution in research settings." Journal of Pharmaceutical Sciences, 2014. PMID: 24375380